This site is intended for Healthcare professionals only.

No Risk Association for Anthracycline Chemotherapy, Cognitive Decline


No Risk Association for Anthracycline Chemotherapy, Cognitive Decline

JAMA Oncology : New data analyses found no association between anthracycline chemotherapy and greater risk of cognitive decline in breast cancer survivors, according to an article published online by JAMA Oncology.

Possible adverse effects of breast cancer treatment on cognitive function have been acknowledged but the risks of specific chemotherapies remain undetermined.

Patricia A. Ganz, M.D., of the UCLA Jonsson Comprehensive Cancer Center, Los Angeles, and coauthors conducted a secondary analysis of Mind Body Study data to examine the risk of lasting cognitive decline with anthracycline-based chemotherapy.

Breast cancer survivors had baseline neuropsychological evaluations within three months after primary treatments (n=190), at six months (n=173), at one year (n=173) and at an average of 4.8 years after treatment (n=102). The neuropsychological tested picked for the analyses measured memory, processing speed and executive function.

The authors report that cognitive function after cancer treatment in memory, processing speeds and executive function was comparable among those women who received chemotherapy with or without anthracycline and those who did not receive chemotherapy. Over time, cognitive function also was comparable between the groups up to seven years after treatment, according to the study. The authors also note that they did not find an association between anthracycline exposure and neuropsychological performance on any measure they examined.

The authors acknowledge their study results are in contrast to other findings.

“In conclusion, in this study we could not find evidence to support the claim that anthracycline treatment confers greater risk of cognitive decline for breast cancer survivors,” the study concludes.

The following two tabs change content below.
supriya kashyap

supriya kashyap

Supriya Kashyap Joined Medical Dialogue as Reporter in 2015 . she covers all the medical specialty news in different medical categories. She also covers the Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in medical filed. She is a graduate from Delhi University. She can be contacted at supriya.kashyap@medicaldialogues.in Contact no. 011-43720751
Source: Jama

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted